Listed

ANI Pharmaceuticals Inc

ANIPNasdaqCIK 1023024HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$266.0m, Q2 FY2026
Operating income$40.5m, Q2 FY2026
Net income$24.7m, Q2 FY2026
ANI Pharmaceuticals Inc, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m132Revenue, Q3 FY2023, three months to 2023-09-30$131.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-08, accession 0001023024-24-000102.Report this figure132Revenue, Q4 FY2023, three months to 2023-12-31$131.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001023024-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure137Revenue, Q1 FY2024, three months to 2024-03-31$137.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-09, accession 0001023024-25-000046.Report this figure138Revenue, Q2 FY2024, three months to 2024-06-30$138.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-08, accession 0001023024-25-000082.Report this figure148Revenue, Q3 FY2024, three months to 2024-09-30$148.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001023024-25-000108.Report this figure191Revenue, Q4 FY2024, three months to 2024-12-31$190.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001023024-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure197Revenue, Q1 FY2025, three months to 2025-03-31$197.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure211Revenue, Q2 FY2025, three months to 2025-06-30$211.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure228Revenue, Q3 FY2025, three months to 2025-09-30$227.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001023024-25-000108.Report this figure247Revenue, Q4 FY2025, three months to 2025-12-31$247.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001023024-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure237Revenue, Q1 FY2026, three months to 2026-03-31$237.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure266Revenue, Q2 FY2026, three months to 2026-06-30$266.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m11.1Research and development, Q3 FY2023, three months to 2023-09-30$11.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-08, accession 0001023024-24-000102.Report this figure9.9Research and development, Q4 FY2023, three months to 2023-12-31$9.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-27, accession 0001023024-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure10.5Research and development, Q1 FY2024, three months to 2024-03-31$10.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-09, accession 0001023024-25-000046.Report this figure7.3Research and development, Q2 FY2024, three months to 2024-06-30$7.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-08, accession 0001023024-25-000082.Report this figure10.1Research and development, Q3 FY2024, three months to 2024-09-30$10.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-07, accession 0001023024-25-000108.Report this figure16.6Research and development, Q4 FY2024, three months to 2024-12-31$16.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-27, accession 0001023024-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure10.6Research and development, Q1 FY2025, three months to 2025-03-31$10.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure16.5Research and development, Q2 FY2025, three months to 2025-06-30$16.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure12.3Research and development, Q3 FY2025, three months to 2025-09-30$12.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-07, accession 0001023024-25-000108.Report this figure12.3Research and development, Q4 FY2025, three months to 2025-12-31$12.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-27, accession 0001023024-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure10.6Research and development, Q1 FY2026, three months to 2026-03-31$10.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure14.7Research and development, Q2 FY2026, three months to 2026-06-30$14.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure
Selling, general and administrative$m42.0Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$42.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-08, accession 0001023024-24-000102.Report this figure44.5Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$44.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-27, accession 0001023024-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure48.0Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$48.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-09, accession 0001023024-25-000046.Report this figure52.8Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$52.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-08, accession 0001023024-25-000082.Report this figure79.1Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$79.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-07, accession 0001023024-25-000108.Report this figure69.7Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$69.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-27, accession 0001023024-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure76.5Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$76.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure81.8Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$81.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure76.7Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$76.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-07, accession 0001023024-25-000108.Report this figure82.8Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$82.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-27, accession 0001023024-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure73.7Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$73.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure91.7Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$91.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure
Operating income$m17.9Operating income, Q3 FY2023, three months to 2023-09-30$17.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-08, accession 0001023024-24-000102.Report this figure6.7Operating income, Q4 FY2023, three months to 2023-12-31$6.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001023024-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure20.3Operating income, Q1 FY2024, three months to 2024-03-31$20.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-09, accession 0001023024-25-000046.Report this figure5.2Operating income, Q2 FY2024, three months to 2024-06-30$5.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-08, accession 0001023024-25-000082.Report this figure(20.5)Operating income, Q3 FY2024, three months to 2024-09-30−$20.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001023024-25-000108.Report this figure(4.4)Operating income, Q4 FY2024, three months to 2024-12-31−$4.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001023024-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure26.2Operating income, Q1 FY2025, three months to 2025-03-31$26.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure13.9Operating income, Q2 FY2025, three months to 2025-06-30$13.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure36.2Operating income, Q3 FY2025, three months to 2025-09-30$36.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001023024-25-000108.Report this figure34.8Operating income, Q4 FY2025, three months to 2025-12-31$34.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001023024-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure38.9Operating income, Q1 FY2026, three months to 2026-03-31$38.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure40.5Operating income, Q2 FY2026, three months to 2026-06-30$40.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$m1.6Income tax, Q3 FY2023, three months to 2023-09-30$1.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-08, accession 0001023024-24-000102.Report this figure(0.2)Income tax, Q4 FY2023, three months to 2023-12-31−$208.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-27, accession 0001023024-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure7.1Income tax, Q1 FY2024, three months to 2024-03-31$7.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-09, accession 0001023024-25-000046.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-08, accession 0001023024-25-000082.Report this figure(7.3)Income tax, Q3 FY2024, three months to 2024-09-30−$7.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-07, accession 0001023024-25-000108.Report this figure(3.5)Income tax, Q4 FY2024, three months to 2024-12-31−$3.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-27, accession 0001023024-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure4.3Income tax, Q1 FY2025, three months to 2025-03-31$4.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure2.0Income tax, Q2 FY2025, three months to 2025-06-30$2.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure7.2Income tax, Q3 FY2025, three months to 2025-09-30$7.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-07, accession 0001023024-25-000108.Report this figure4.0Income tax, Q4 FY2025, three months to 2025-12-31$4.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-27, accession 0001023024-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure10.7Income tax, Q1 FY2026, three months to 2026-03-31$10.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure12.4Income tax, Q2 FY2026, three months to 2026-06-30$12.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure
Net income$m9.9Net income, Q3 FY2023, three months to 2023-09-30$9.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-08, accession 0001023024-24-000102.Report this figure1.2Net income, Q4 FY2023, three months to 2023-12-31$1.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001023024-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure18.2Net income, Q1 FY2024, three months to 2024-03-31$18.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-09, accession 0001023024-25-000046.Report this figure(2.3)Net income, Q2 FY2024, three months to 2024-06-30−$2.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-08, accession 0001023024-25-000082.Report this figure(24.2)Net income, Q3 FY2024, three months to 2024-09-30−$24.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001023024-25-000108.Report this figure(10.3)Net income, Q4 FY2024, three months to 2024-12-31−$10.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001023024-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure15.7Net income, Q1 FY2025, three months to 2025-03-31$15.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure8.5Net income, Q2 FY2025, three months to 2025-06-30$8.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure26.6Net income, Q3 FY2025, three months to 2025-09-30$26.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001023024-25-000108.Report this figure27.5Net income, Q4 FY2025, three months to 2025-12-31$27.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001023024-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure29.5Net income, Q1 FY2026, three months to 2026-03-31$29.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure24.7Net income, Q2 FY2026, three months to 2026-06-30$24.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure
Diluted EPS$ per share0.45Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.45 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-08, accession 0001023024-24-000102.Report this figurenot reported0.82Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.82 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-09, accession 0001023024-25-000046.Report this figure(0.14)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-08, accession 0001023024-25-000082.Report this figure(1.27)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$1.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001023024-25-000108.Report this figurenot reported0.69Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.69 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure0.36Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.36 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure1.13Diluted EPS, Q3 FY2025, three months to 2025-09-30$1.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001023024-25-000108.Report this figurenot reported1.28Diluted EPS, Q1 FY2026, three months to 2026-03-31$1.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure1.05Diluted EPS, Q2 FY2026, three months to 2026-06-30$1.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure
Basic EPS$ per share0.46Basic EPS, Q3 FY2023, three months to 2023-09-30$0.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-08, accession 0001023024-24-000102.Report this figurenot reported0.84Basic EPS, Q1 FY2024, three months to 2024-03-31$0.84 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-09, accession 0001023024-25-000046.Report this figure(0.14)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-08, accession 0001023024-25-000082.Report this figure(1.27)Basic EPS, Q3 FY2024, three months to 2024-09-30−$1.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-07, accession 0001023024-25-000108.Report this figurenot reported0.70Basic EPS, Q1 FY2025, three months to 2025-03-31$0.70 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure0.37Basic EPS, Q2 FY2025, three months to 2025-06-30$0.37 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure1.19Basic EPS, Q3 FY2025, three months to 2025-09-30$1.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-07, accession 0001023024-25-000108.Report this figurenot reported1.31Basic EPS, Q1 FY2026, three months to 2026-03-31$1.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure1.09Basic EPS, Q2 FY2026, three months to 2026-06-30$1.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure

Balance sheet

Cash and equivalents$360.2m, Q2 FY2026
Long-term debt$280.2m, Q2 FY2026
Shareholders' equity$597.2m, Q2 FY2026
ANI Pharmaceuticals Inc, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m193Cash and equivalents, Q3 FY2023, at 2023-09-30$193.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-08, accession 0001023024-23-000043.Report this figure221Cash and equivalents, FY2023, at 2023-12-31$221.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-27, accession 0001023024-26-000014.Report this figure229Cash and equivalents, Q1 FY2024, at 2024-03-31$228.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-10, accession 0001023024-24-000057.Report this figure240Cash and equivalents, Q2 FY2024, at 2024-06-30$240.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-06, accession 0001023024-24-000085.Report this figure145Cash and equivalents, Q3 FY2024, at 2024-09-30$145.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-07, accession 0001023024-25-000108.Report this figure145Cash and equivalents, FY2024, at 2024-12-31$144.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure150Cash and equivalents, Q1 FY2025, at 2025-03-31$149.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure218Cash and equivalents, Q2 FY2025, at 2025-06-30$217.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure263Cash and equivalents, Q3 FY2025, at 2025-09-30$262.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-07, accession 0001023024-25-000108.Report this figure286Cash and equivalents, FY2025, at 2025-12-31$285.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure311Cash and equivalents, Q1 FY2026, at 2026-03-31$311.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure360Cash and equivalents, Q2 FY2026, at 2026-06-30$360.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure
Current assets$m497Current assets, Q3 FY2023, at 2023-09-30$497.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0001023024-23-000043.Report this figure520Current assets, FY2023, at 2023-12-31$519.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-28, accession 0001023024-25-000015.Report this figure541Current assets, Q1 FY2024, at 2024-03-31$540.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-10, accession 0001023024-24-000057.Report this figure555Current assets, Q2 FY2024, at 2024-06-30$555.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-06, accession 0001023024-24-000085.Report this figure521Current assets, Q3 FY2024, at 2024-09-30$521.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-08, accession 0001023024-24-000102.Report this figure528Current assets, FY2024, at 2024-12-31$528.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-27, accession 0001023024-26-000014.Report this figure536Current assets, Q1 FY2025, at 2025-03-31$536.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-09, accession 0001023024-25-000046.Report this figure603Current assets, Q2 FY2025, at 2025-06-30$602.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-08, accession 0001023024-25-000082.Report this figure698Current assets, Q3 FY2025, at 2025-09-30$698.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-07, accession 0001023024-25-000108.Report this figure753Current assets, FY2025, at 2025-12-31$753.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure747Current assets, Q1 FY2026, at 2026-03-31$747.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure825Current assets, Q2 FY2026, at 2026-06-30$825.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure
Total assets$m890Total assets, Q3 FY2023, at 2023-09-30$889.9m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0001023024-23-000043.Report this figure904Total assets, FY2023, at 2023-12-31$904.4m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-28, accession 0001023024-25-000015.Report this figure915Total assets, Q1 FY2024, at 2024-03-31$914.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-10, accession 0001023024-24-000057.Report this figure921Total assets, Q2 FY2024, at 2024-06-30$920.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-06, accession 0001023024-24-000085.Report this figure1,287Total assets, Q3 FY2024, at 2024-09-30$1.29bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-08, accession 0001023024-24-000102.Report this figure1,284Total assets, FY2024, at 2024-12-31$1.28bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-27, accession 0001023024-26-000014.Report this figure1,292Total assets, Q1 FY2025, at 2025-03-31$1.29bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-09, accession 0001023024-25-000046.Report this figure1,343Total assets, Q2 FY2025, at 2025-06-30$1.34bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-08, accession 0001023024-25-000082.Report this figure1,408Total assets, Q3 FY2025, at 2025-09-30$1.41bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-07, accession 0001023024-25-000108.Report this figure1,440Total assets, FY2025, at 2025-12-31$1.44bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure1,422Total assets, Q1 FY2026, at 2026-03-31$1.42bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure1,494Total assets, Q2 FY2026, at 2026-06-30$1.49bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure
Current liabilities$m134Current liabilities, Q3 FY2023, at 2023-09-30$134.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0001023024-23-000043.Report this figure145Current liabilities, FY2023, at 2023-12-31$145.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-28, accession 0001023024-25-000015.Report this figure137Current liabilities, Q1 FY2024, at 2024-03-31$136.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-10, accession 0001023024-24-000057.Report this figure140Current liabilities, Q2 FY2024, at 2024-06-30$140.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-06, accession 0001023024-24-000085.Report this figure190Current liabilities, Q3 FY2024, at 2024-09-30$189.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-08, accession 0001023024-24-000102.Report this figure194Current liabilities, FY2024, at 2024-12-31$194.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-27, accession 0001023024-26-000014.Report this figure202Current liabilities, Q1 FY2025, at 2025-03-31$201.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-09, accession 0001023024-25-000046.Report this figure237Current liabilities, Q2 FY2025, at 2025-06-30$236.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-08, accession 0001023024-25-000082.Report this figure271Current liabilities, Q3 FY2025, at 2025-09-30$270.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-07, accession 0001023024-25-000108.Report this figure278Current liabilities, FY2025, at 2025-12-31$278.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure240Current liabilities, Q1 FY2026, at 2026-03-31$239.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure284Current liabilities, Q2 FY2026, at 2026-06-30$283.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure
Total liabilities$m435Total liabilities, Q3 FY2023, at 2023-09-30$435.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0001023024-23-000043.Report this figure447Total liabilities, FY2023, at 2023-12-31$446.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-28, accession 0001023024-25-000015.Report this figure438Total liabilities, Q1 FY2024, at 2024-03-31$437.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-10, accession 0001023024-24-000057.Report this figure440Total liabilities, Q2 FY2024, at 2024-06-30$440.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-06, accession 0001023024-24-000085.Report this figure857Total liabilities, Q3 FY2024, at 2024-09-30$856.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-08, accession 0001023024-24-000102.Report this figure856Total liabilities, FY2024, at 2024-12-31$855.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-27, accession 0001023024-26-000014.Report this figure849Total liabilities, Q1 FY2025, at 2025-03-31$849.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-09, accession 0001023024-25-000046.Report this figure881Total liabilities, Q2 FY2025, at 2025-06-30$881.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-08, accession 0001023024-25-000082.Report this figure902Total liabilities, Q3 FY2025, at 2025-09-30$902.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-07, accession 0001023024-25-000108.Report this figure900Total liabilities, FY2025, at 2025-12-31$899.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure860Total liabilities, Q1 FY2026, at 2026-03-31$859.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure897Total liabilities, Q2 FY2026, at 2026-06-30$896.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure
Long-term debt$m285Long-term debt, Q3 FY2023, at 2023-09-30$285.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-08, accession 0001023024-23-000043.Report this figure285Long-term debt, FY2023, at 2023-12-31$284.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-02-28, accession 0001023024-25-000015.Report this figure285Long-term debt, Q1 FY2024, at 2024-03-31$284.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-10, accession 0001023024-24-000057.Report this figure284Long-term debt, Q2 FY2024, at 2024-06-30$284.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-06, accession 0001023024-24-000085.Report this figure313Long-term debt, Q3 FY2024, at 2024-09-30$312.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-08, accession 0001023024-24-000102.Report this figure309Long-term debt, FY2024, at 2024-12-31$309.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-27, accession 0001023024-26-000014.Report this figure305Long-term debt, Q1 FY2025, at 2025-03-31$305.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-09, accession 0001023024-25-000046.Report this figure301Long-term debt, Q2 FY2025, at 2025-06-30$301.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-08, accession 0001023024-25-000082.Report this figure298Long-term debt, Q3 FY2025, at 2025-09-30$297.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-07, accession 0001023024-25-000108.Report this figure292Long-term debt, FY2025, at 2025-12-31$291.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure286Long-term debt, Q1 FY2026, at 2026-03-31$286.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure280Long-term debt, Q2 FY2026, at 2026-06-30$280.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure
Current portion of debt$m0.9Current portion of debt, Q3 FY2023, at 2023-09-30$850.0k. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2023-11-08, accession 0001023024-23-000043.Report this figure0.9Current portion of debt, FY2023, at 2023-12-31$850.0k. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-02-28, accession 0001023024-25-000015.Report this figure0.9Current portion of debt, Q1 FY2024, at 2024-03-31$850.0k. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-05-10, accession 0001023024-24-000057.Report this figure0.9Current portion of debt, Q2 FY2024, at 2024-06-30$850.0k. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-08-06, accession 0001023024-24-000085.Report this figure7.2Current portion of debt, Q3 FY2024, at 2024-09-30$7.2m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-08, accession 0001023024-24-000102.Report this figure9.2Current portion of debt, FY2024, at 2024-12-31$9.2m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-02-27, accession 0001023024-26-000014.Report this figure11.2Current portion of debt, Q1 FY2025, at 2025-03-31$11.2m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-05-09, accession 0001023024-25-000046.Report this figure13.2Current portion of debt, Q2 FY2025, at 2025-06-30$13.2m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-08-08, accession 0001023024-25-000082.Report this figure15.2Current portion of debt, Q3 FY2025, at 2025-09-30$15.2m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-11-07, accession 0001023024-25-000108.Report this figure17.3Current portion of debt, FY2025, at 2025-12-31$17.3m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure19.3Current portion of debt, Q1 FY2026, at 2026-03-31$19.3m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure21.3Current portion of debt, Q2 FY2026, at 2026-06-30$21.3m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure
Shareholders' equity$m430Shareholders' equity, Q3 FY2023, at 2023-09-30$429.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-11-08, accession 0001023024-23-000043.Report this figure433Shareholders' equity, FY2023, at 2023-12-31$432.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-02-28, accession 0001023024-25-000015.Report this figure452Shareholders' equity, Q1 FY2024, at 2024-03-31$452.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-05-10, accession 0001023024-24-000057.Report this figure456Shareholders' equity, Q2 FY2024, at 2024-06-30$455.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-08-06, accession 0001023024-24-000085.Report this figure406Shareholders' equity, Q3 FY2024, at 2024-09-30$405.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-08, accession 0001023024-24-000102.Report this figure404Shareholders' equity, FY2024, at 2024-12-31$403.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-27, accession 0001023024-26-000014.Report this figure419Shareholders' equity, Q1 FY2025, at 2025-03-31$418.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-09, accession 0001023024-25-000046.Report this figure437Shareholders' equity, Q2 FY2025, at 2025-06-30$436.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-08, accession 0001023024-25-000082.Report this figure506Shareholders' equity, Q3 FY2025, at 2025-09-30$505.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001023024-25-000108.Report this figure541Shareholders' equity, FY2025, at 2025-12-31$540.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure562Shareholders' equity, Q1 FY2026, at 2026-03-31$562.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure597Shareholders' equity, Q2 FY2026, at 2026-06-30$597.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure

Cash flow

Operating cash flow$56.7m, Q2 FY2026
Capital expenditure$3.1m, Q2 FY2026
Share repurchases$813.0k, Q2 FY2026
ANI Pharmaceuticals Inc, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m32.2Operating cash flow, Q3 FY2023, three months to 2023-09-30$32.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-08, accession 0001023024-24-000102. Derived: 9-month figure less the 6-month figure.Report this figure44.7Operating cash flow, Q4 FY2023, three months to 2023-12-31$44.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001023024-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure18.3Operating cash flow, Q1 FY2024, three months to 2024-03-31$18.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-09, accession 0001023024-25-000046.Report this figure17.4Operating cash flow, Q2 FY2024, three months to 2024-06-30$17.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-08, accession 0001023024-25-000082. Derived: 6-month figure less the 3-month figure.Report this figure12.5Operating cash flow, Q3 FY2024, three months to 2024-09-30$12.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001023024-25-000108. Derived: 9-month figure less the 6-month figure.Report this figure15.9Operating cash flow, Q4 FY2024, three months to 2024-12-31$15.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001023024-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure35.0Operating cash flow, Q1 FY2025, three months to 2025-03-31$35.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure75.8Operating cash flow, Q2 FY2025, three months to 2025-06-30$75.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001023024-26-000069. Derived: 6-month figure less the 3-month figure.Report this figure44.1Operating cash flow, Q3 FY2025, three months to 2025-09-30$44.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001023024-25-000108. Derived: 9-month figure less the 6-month figure.Report this figure30.4Operating cash flow, Q4 FY2025, three months to 2025-12-31$30.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001023024-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure58.4Operating cash flow, Q1 FY2026, three months to 2026-03-31$58.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure56.7Operating cash flow, Q2 FY2026, three months to 2026-06-30$56.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001023024-26-000069. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m1.7Capital expenditure, Q3 FY2023, three months to 2023-09-30$1.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-08, accession 0001023024-24-000102. Derived: 9-month figure less the 6-month figure.Report this figure2.3Capital expenditure, Q4 FY2023, three months to 2023-12-31$2.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001023024-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure4.6Capital expenditure, Q1 FY2024, three months to 2024-03-31$4.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-09, accession 0001023024-25-000046.Report this figure4.4Capital expenditure, Q2 FY2024, three months to 2024-06-30$4.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-08, accession 0001023024-25-000082. Derived: 6-month figure less the 3-month figure.Report this figure4.8Capital expenditure, Q3 FY2024, three months to 2024-09-30$4.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-07, accession 0001023024-25-000108. Derived: 9-month figure less the 6-month figure.Report this figure2.4Capital expenditure, Q4 FY2024, three months to 2024-12-31$2.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001023024-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure2.5Capital expenditure, Q1 FY2025, three months to 2025-03-31$2.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure4.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$4.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-07, accession 0001023024-26-000069. Derived: 6-month figure less the 3-month figure.Report this figure6.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$6.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-07, accession 0001023024-25-000108. Derived: 9-month figure less the 6-month figure.Report this figure1.2Capital expenditure, Q4 FY2025, three months to 2025-12-31$1.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001023024-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure6.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$6.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure3.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$3.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-07, accession 0001023024-26-000069. Derived: 6-month figure less the 3-month figure.Report this figure
Dividends paid$m0.4Dividends paid, Q3 FY2023, three months to 2023-09-30$406.0k. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2024-11-08, accession 0001023024-24-000102. Derived: 9-month figure less the 6-month figure.Report this figure0.4Dividends paid, Q4 FY2023, three months to 2023-12-31$406.0k. XBRL concept us-gaap:PaymentsOfDividends. 10-K filed 2026-02-27, accession 0001023024-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure0.4Dividends paid, Q1 FY2024, three months to 2024-03-31$406.0k. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-05-09, accession 0001023024-25-000046.Report this figure0.4Dividends paid, Q2 FY2024, three months to 2024-06-30$407.0k. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-08-08, accession 0001023024-25-000082. Derived: 6-month figure less the 3-month figure.Report this figure0.4Dividends paid, Q3 FY2024, three months to 2024-09-30$406.0k. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-11-07, accession 0001023024-25-000108. Derived: 9-month figure less the 6-month figure.Report this figure0.4Dividends paid, Q4 FY2024, three months to 2024-12-31$406.0k. XBRL concept us-gaap:PaymentsOfDividends. 10-K filed 2026-02-27, accession 0001023024-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure0.4Dividends paid, Q1 FY2025, three months to 2025-03-31$406.0k. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure0.4Dividends paid, Q2 FY2025, three months to 2025-06-30$407.0k. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-08-07, accession 0001023024-26-000069. Derived: 6-month figure less the 3-month figure.Report this figure0.3Dividends paid, Q3 FY2025, three months to 2025-09-30$344.0k. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-11-07, accession 0001023024-25-000108. Derived: 9-month figure less the 6-month figure.Report this figure0.0Dividends paid, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsOfDividends. 10-K filed 2026-02-27, accession 0001023024-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure0.0Dividends paid, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure0.0Dividends paid, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-08-07, accession 0001023024-26-000069. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$m0.7Share repurchases, Q3 FY2023, three months to 2023-09-30$670.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-08, accession 0001023024-24-000102. Derived: 9-month figure less the 6-month figure.Report this figure0.2Share repurchases, Q4 FY2023, three months to 2023-12-31$231.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-27, accession 0001023024-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure8.7Share repurchases, Q1 FY2024, three months to 2024-03-31$8.7m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-05-09, accession 0001023024-25-000046.Report this figure1.3Share repurchases, Q2 FY2024, three months to 2024-06-30$1.3m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-08-08, accession 0001023024-25-000082. Derived: 6-month figure less the 3-month figure.Report this figure0.7Share repurchases, Q3 FY2024, three months to 2024-09-30$680.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-07, accession 0001023024-25-000108. Derived: 9-month figure less the 6-month figure.Report this figure0.3Share repurchases, Q4 FY2024, three months to 2024-12-31$318.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-27, accession 0001023024-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure10.0Share repurchases, Q1 FY2025, three months to 2025-03-31$10.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure0.6Share repurchases, Q2 FY2025, three months to 2025-06-30$551.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-07, accession 0001023024-26-000069. Derived: 6-month figure less the 3-month figure.Report this figure1.0Share repurchases, Q3 FY2025, three months to 2025-09-30$1.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-07, accession 0001023024-25-000108. Derived: 9-month figure less the 6-month figure.Report this figure0.6Share repurchases, Q4 FY2025, three months to 2025-12-31$611.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-27, accession 0001023024-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure19.8Share repurchases, Q1 FY2026, three months to 2026-03-31$19.8m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure0.8Share repurchases, Q2 FY2026, three months to 2026-06-30$813.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-07, accession 0001023024-26-000069. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)21.91m, Q2 FY2026
ANI Pharmaceuticals Inc, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares16.3Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3016,303,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0001023024-23-000043.Report this figure16.5Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3116,531,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-10, accession 0001023024-24-000057.Report this figure17.9Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3017,855,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-06, accession 0001023024-24-000085.Report this figure19.1Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3019,125,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-08, accession 0001023024-24-000102.Report this figure19.4Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3119,422,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-09, accession 0001023024-25-000046.Report this figure19.3Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3019,321,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-08, accession 0001023024-25-000082.Report this figure19.4Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3019,404,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-07, accession 0001023024-25-000108.Report this figure20.0Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3120,046,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure20.3Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3020,308,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure21.1Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3021,093,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-07, accession 0001023024-25-000108.Report this figure21.5Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3121,544,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-08, accession 0001023024-26-000050.Report this figure21.9Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3021,915,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-07, accession 0001023024-26-000069.Report this figure

Shares outstanding: 24.42mShares outstanding, period not labelled, at 2013-02-2824,422,240 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-K filed 2013-02-28, accession 0001104659-13-016148.Report this figure at Feb 28, 2013, from the cover of the 10-K filed Feb 28, 2013.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. Listed shows no prices and gives no investment advice.